Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Xanodyne names CEO

Executive Summary

Xanodyne's new CEO is former Shire U.S. CEO William Nuerge. The move reunites Nuerge with Roger Griggs, who served as Xanodyne CEO until the Nov. 8 switch; Griggs will continue as chairman of Xanodyne's board. Griggs was Richwood's CEO and Nuerge was the company's COO when it merged with Shire in 1997. Nuerge was Shire U.S. CEO from 1998 until January 2004 when his position was eliminated as part of the company's consolidation of its U.S. facilities. He performed consulting work for Xanodyne in the interim before joining as CEO...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS044988

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel